Drug Guidance for Subsidy 25/10/2024 Recombinant zoster vaccine for the prevention of herpes zoster and post-herpetic neuralgia NRThe Ministry of Health’s Drug Advisory Committee has not recommended recombinant zoster vacc... See all × 25/10/2024 Recombinant zoster vaccine for the prevention of herpes zoster and post-herpetic neuralgia NRThe Ministry of Health’s Drug Advisory Committee has not recommended recombinant zoster vaccine (RZV) for listing on the MOH Subsidised Vaccine List for the prevention of herpes zoster (HZ) and post-herpetic neuralgia in adults 50 years of age or older, and adults 18 years of age or older at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy. The decision was based on the unfavourable cost-effectiveness of RZV and the absence of a price-volume agreement in the company’s proposal.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Shingrix Injection, Powder, Lyophilized, For Liposomal Suspension 50 mcg/0.5 mL Alexandra Hospital Changi General Hospital KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre National Skin Centre Ng Teng Fong General Hospital National University Hospital National University Polyclinics Sengkang General Hospital Singapore General Hospital Woodlands Health Campus
INTRAMUSCULAR Select a brand starting with the letter: S SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML [SIN16079P]